<PubmedArticle><MedlineCitation Status="Publisher" Owner="NLM"><PMID Version="1">39193696</PMID><DateRevised><Year>2024</Year><Month>08</Month><Day>28</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">2542-5641</ISSN><JournalIssue CitedMedium="Internet"><PubDate><Year>2024</Year><Month>Aug</Month><Day>28</Day></PubDate></JournalIssue><Title>Chinese medical journal</Title><ISOAbbreviation>Chin Med J (Engl)</ISOAbbreviation></Journal><ArticleTitle>Role of lifestyle factors on the development and long-term prognosis of pneumonia and cardiovascular disease in the Chinese population.</ArticleTitle><ELocationID EIdType="doi" ValidYN="Y">10.1097/CM9.0000000000003160</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Whether adherence to a healthy lifestyle is associated with a lower risk of developing pneumonia and a better long-term prognosis remains unclear. This study aimed to investigate associations of individual and combined lifestyle factors (LFs) with the incidence risk and long-term prognosis of pneumonia hospitalization.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">Using data from the China Kadoorie Biobank study, we used the multistate models to investigate the role of five high-risk LFs, including smoking, excessive alcohol drinking, unhealthy dietary habits, physical inactivity, and unhealthy body shape, alone or in combination in the transitions from a generally healthy state at baseline to pneumonia hospitalization or cardiovascular disease (CVD, regarded as a reference outcome), and subsequently to mortality.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Most of the five high-risk LFs were associated with increased risks of transitions from baseline to pneumonia and from pneumonia to death, but with different risk estimates. The greater the number of high-risk LFs, the higher the risk of developing pneumonia and long-term mortality risk after pneumonia, with the strength of associations comparable to that of LFs and CVD. Compared to participants with 0-1 high-risk LF, the adjusted hazard ratios (HRs) and 95% confidence intervals (CIs) for transitions from baseline to pneumonia and from pneumonia to death in those with five high-risk LFs were 1.43 (1.28-1.60) and 1.98 (1.61-2.42), respectively. Correspondingly, the respective HRs (95% CIs) for transitions from baseline to CVD and from CVD to death were 2.00 (1.89-2.11) and 1.44 (1.30-1.59), respectively. The risk estimates changed slightly when further adjusting for the presence of major chronic diseases.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">In this Chinese population, unhealthy LFs were associated with an increased incidence and long-term mortality risk of pneumonia.</AbstractText><CopyrightInformation>Copyright © 2024 The Chinese Medical Association, produced by Wolters Kluwer, Inc. under the CC-BY-NC-ND license.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Hu</LastName><ForeName>Yizhen</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Epidemiology and Biostatistics, School of Public Health, Peking University, Beijing 100191, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Epidemiology and Health Statistics, School of Public Health, Fujian Medical University, Fuzhou, Fujian 350000, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sun</LastName><ForeName>Qiufen</ForeName><Initials>Q</Initials><AffiliationInfo><Affiliation>Department of Epidemiology and Biostatistics, School of Public Health, Peking University, Beijing 100191, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Han</LastName><ForeName>Yuting</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Epidemiology and Biostatistics, School of Public Health, Peking University, Beijing 100191, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yu</LastName><ForeName>Canqing</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Epidemiology and Biostatistics, School of Public Health, Peking University, Beijing 100191, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Peking University Center for Public Health and Epidemic Preparedness and Response, Beijing 100191, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Key Laboratory of Epidemiology of Major Diseases (Peking University), Ministry of Education, Beijing 100191, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Guo</LastName><ForeName>Yu</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Fuwai Hospital Chinese Academy of Medical Sciences, Beijing 100037, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sun</LastName><ForeName>Dianjianyi</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Department of Epidemiology and Biostatistics, School of Public Health, Peking University, Beijing 100191, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Peking University Center for Public Health and Epidemic Preparedness and Response, Beijing 100191, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Key Laboratory of Epidemiology of Major Diseases (Peking University), Ministry of Education, Beijing 100191, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pang</LastName><ForeName>Yuanjie</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Epidemiology and Biostatistics, School of Public Health, Peking University, Beijing 100191, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Peking University Center for Public Health and Epidemic Preparedness and Response, Beijing 100191, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Key Laboratory of Epidemiology of Major Diseases (Peking University), Ministry of Education, Beijing 100191, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pei</LastName><ForeName>Pei</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Peking University Center for Public Health and Epidemic Preparedness and Response, Beijing 100191, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yang</LastName><ForeName>Ling</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Medical Research Council Population Health Research Unit, University of Oxford, Oxford OX3 7LF, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Clinical Trial Service Unit and Epidemiological Studies Unit, Nuffield Department of Population Health, University of Oxford, Oxford OX3 7LF, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chen</LastName><ForeName>Yiping</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Medical Research Council Population Health Research Unit, University of Oxford, Oxford OX3 7LF, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Clinical Trial Service Unit and Epidemiological Studies Unit, Nuffield Department of Population Health, University of Oxford, Oxford OX3 7LF, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Du</LastName><ForeName>Huaidong</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Medical Research Council Population Health Research Unit, University of Oxford, Oxford OX3 7LF, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Clinical Trial Service Unit and Epidemiological Studies Unit, Nuffield Department of Population Health, University of Oxford, Oxford OX3 7LF, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Mengwei</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>NCDs Prevention and Control Department, Henan CDC, Zhengzhou, Henan 450016, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Stevens</LastName><ForeName>Rebecca</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Clinical Trial Service Unit and Epidemiological Studies Unit, Nuffield Department of Population Health, University of Oxford, Oxford OX3 7LF, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chen</LastName><ForeName>Junshi</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>China National Center for Food Safety Risk Assessment, Beijing 100022, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chen</LastName><ForeName>Zhengming</ForeName><Initials>Z</Initials><AffiliationInfo><Affiliation>Clinical Trial Service Unit and Epidemiological Studies Unit, Nuffield Department of Population Health, University of Oxford, Oxford OX3 7LF, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Liming</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Epidemiology and Biostatistics, School of Public Health, Peking University, Beijing 100191, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Peking University Center for Public Health and Epidemic Preparedness and Response, Beijing 100191, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Key Laboratory of Epidemiology of Major Diseases (Peking University), Ministry of Education, Beijing 100191, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lv</LastName><ForeName>Jun</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Epidemiology and Biostatistics, School of Public Health, Peking University, Beijing 100191, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Peking University Center for Public Health and Epidemic Preparedness and Response, Beijing 100191, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Key Laboratory of Epidemiology of Major Diseases (Peking University), Ministry of Education, Beijing 100191, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>State Key Laboratory of Vascular Homeostasis and Remodeling, Peking University, Beijing 100191, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><CollectiveName>China Kadoorie Biobank Collaborative Group</CollectiveName></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>08</Month><Day>28</Day></ArticleDate></Article><MedlineJournalInfo><Country>China</Country><MedlineTA>Chin Med J (Engl)</MedlineTA><NlmUniqueID>7513795</NlmUniqueID><ISSNLinking>0366-6999</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>7</Month><Day>27</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>8</Month><Day>28</Day><Hour>8</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>8</Month><Day>28</Day><Hour>8</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>8</Month><Day>28</Day><Hour>4</Hour><Minute>53</Minute></PubMedPubDate></History><PublicationStatus>aheadofprint</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39193696</ArticleId><ArticleId IdType="doi">10.1097/CM9.0000000000003160</ArticleId><ArticleId IdType="pii">00029330-990000000-01200</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>GBD 2019 Diseases and Injuries Collaborators. Global burden of 369 diseases and injuries in 204 countries and territories, 1990–2019: A systematic analysis for the Global Burden of Disease Study 2019. Lancet 2020;396:1204–1222. doi: 10.1016/S0140-6736(20)30925-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(20)30925-9</ArticleId></ArticleIdList></Reference><Reference><Citation>Quinton LJ, Walkey AJ, Mizgerd JP. Integrative physiology of pneumonia. Physiol Rev 2018;98:1417–1464. doi: 10.1152/physrev.00032.2017.</Citation><ArticleIdList><ArticleId IdType="doi">10.1152/physrev.00032.2017</ArticleId></ArticleIdList></Reference><Reference><Citation>Hu Y, Han Y, Yu C, Guo Y, Pei P, Yang L, et al. The hospitalization burden of all-cause pneumonia in China: A population-based study, 2009–2017. Lancet Reg Health West Pac 2022;22:100443. doi: 10.1016/j.lanwpc.2022.100443.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.lanwpc.2022.100443</ArticleId></ArticleIdList></Reference><Reference><Citation>Han X, Wang H, Chen L, Wang Y, Li H, Zhou F, et al. Impact of inhaled corticosteroid use on elderly chronic pulmonary disease patients with community acquired pneumonia. Chin Med J 2024;137:241–243. doi: 10.1097/CM9.0000000000002936.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/CM9.0000000000002936</ArticleId></ArticleIdList></Reference><Reference><Citation>Monye I, Adelowo AB. Strengthening immunity through healthy lifestyle practices: Recommendations for lifestyle interventions in the management of COVID-19. Lifestyle Medicine 2020;1:e7. doi: 10.1002/lim2.7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/lim2.7</ArticleId></ArticleIdList></Reference><Reference><Citation>Almirall J, Serra-Prat M, Bolibar I, Balasso V. Risk factors for community-acquired pneumonia in adults: A systematic review of observational studies. Respiration 2017;94:299–311. doi: 10.1159/000479089.</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000479089</ArticleId></ArticleIdList></Reference><Reference><Citation>Torres A, Peetermans WE, Viegi G, Blasi F. Risk factors for community-acquired pneumonia in adults in Europe: A literature review. Thorax 2013;68:1057–1065. doi: 10.1136/thoraxjnl-2013-204282.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/thoraxjnl-2013-204282</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee J, Kim K, Jo YH, Lee JH, Kim J, Chung H, et al. Severe thinness is associated with mortality in patients with community-acquired pneumonia: A prospective observational study. Am J Emerg Med 2015;33:209–213. doi: 10.1016/j.ajem.2014.11.019.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ajem.2014.11.019</ArticleId></ArticleIdList></Reference><Reference><Citation>King P, Mortensen EM, Bollinger M, Restrepo MI, Copeland LA, Pugh MJ, et al. Impact of obesity on outcomes for patients hospitalised with pneumonia. Eur Respir J 2013;41:929–934. doi: 10.1183/09031936.00185211.</Citation><ArticleIdList><ArticleId IdType="doi">10.1183/09031936.00185211</ArticleId></ArticleIdList></Reference><Reference><Citation>Singanayagam A, Singanayagam A, Chalmers JD. Obesity is associated with improved survival in community-acquired pneumonia. Eur Respir J 2013;42:180–187. doi: 10.1183/09031936.00115312.</Citation><ArticleIdList><ArticleId IdType="doi">10.1183/09031936.00115312</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim RY, Glick C, Furmanek S, Ramirez JA, Cavallazzi R. Association between body mass index and mortality in hospitalised patients with community-acquired pneumonia. ERJ Open Res 2021;7:00736–2020. doi: 10.1183/23120541.00736-2020.</Citation><ArticleIdList><ArticleId IdType="doi">10.1183/23120541.00736-2020</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang H, Lee CC, Chou EH, Hsu WT, Robinson RD, Su KY, et al. Mortality association between obesity and pneumonia using a dual restricted cohort model. Obes Res Clin Pract 2020;14:350–359. doi: 10.1016/j.orcp.2019.09.007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.orcp.2019.09.007</ArticleId></ArticleIdList></Reference><Reference><Citation>Song JH, Thamlikitkul V, Hsueh PR. Clinical and economic burden of community-acquired pneumonia amongst adults in the Asia-Pacific region. Int J Antimicrob Agents 2011;38:108–117. doi: 10.1016/j.ijantimicag.2011.02.017.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijantimicag.2011.02.017</ArticleId></ArticleIdList></Reference><Reference><Citation>Corrales-Medina VF, Musher DM, Wells GA, Chirinos JA, Chen L, Fine MJ. Cardiac complications in patients with community-acquired pneumonia: Incidence, timing, risk factors, and association with short-term mortality. Circulation 2012;125:773–781. doi: 10.1161/CIRCULATIONAHA.111.040766.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCULATIONAHA.111.040766</ArticleId></ArticleIdList></Reference><Reference><Citation>Mozaffarian D, Wilson PW, Kannel WB. Beyond established and novel risk factors: Lifestyle risk factors for cardiovascular disease. Circulation 2008;117:3031–3038. doi: 10.1161/circulationaha.107.738732.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/circulationaha.107.738732</ArticleId></ArticleIdList></Reference><Reference><Citation>Han Y, Hu Y, Yu C, Guo Y, Pei P, Yang L, et al. Lifestyle, cardiometabolic disease, and multimorbidity in a prospective Chinese study. Eur Heart J 2021;42:3374–3384. doi: 10.1093/eurheartj/ehab413.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/eurheartj/ehab413</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen Z, Lee L, Chen J, Collins R, Wu F, Guo Y, et al. Cohort profile: The Kadoorie Study of Chronic Disease in China (KSCDC). Int J Epidemiol 2005;34:1243–1249. doi: 10.1093/ije/dyi174.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ije/dyi174</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen Z, Chen J, Collins R, Guo Y, Peto R, Wu F, et al. China Kadoorie Biobank of 0.5 million people: Survey methods, baseline characteristics and long-term follow-up. Int J Epidemiol 2011;40:1652–1666. doi: 10.1093/ije/dyr120.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ije/dyr120</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang G, Hu J, Rao KQ, Ma J, Rao C, Lopez AD. Mortality registration and surveillance in China: History, current situation and challenges. Popul Health Metr 2005;3:3. doi: 10.1186/1478-7954-3-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1478-7954-3-3</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhu N, Yu C, Guo Y, Bian Z, Han Y, Yang L, et al. Adherence to a healthy lifestyle and all-cause and cause-specific mortality in Chinese adults: A 10-year prospective study of 0.5 million people. Int J Behav Nutr Phys Act 2019;16:98. doi: 10.1186/s12966-019-0860-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12966-019-0860-z</ArticleId></ArticleIdList></Reference><Reference><Citation>Putter H, Fiocco M, Geskus RB. Tutorial in biostatistics: Competing risks and multi-state models. Stat Med 2007;26:2389–2430. doi: 10.1002/sim.2712.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/sim.2712</ArticleId></ArticleIdList></Reference><Reference><Citation>de Wreede LC, Fiocco M, Putter H. The mstate package for estimation and prediction in non- and semi-parametric multi-state and competing risks models. Comput Methods Programs Biomed 2010;99:261–274. doi: 10.1016/j.cmpb.2010.01.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cmpb.2010.01.001</ArticleId></ArticleIdList></Reference><Reference><Citation>Baik I, Curhan GC, Rimm EB, Bendich A, Willett WC, Fawzi WW. A prospective study of age and lifestyle factors in relation to community-acquired pneumonia in US men and women. Arch Intern Med 2000;160:3082–3088. doi: 10.1001/archinte.160.20.3082.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/archinte.160.20.3082</ArticleId></ArticleIdList></Reference><Reference><Citation>Mannino DM, Davis KJ, Kiri VA. Chronic obstructive pulmonary disease and hospitalizations for pneumonia in a US cohort. Respir Med 2009;103:224–229. doi: 10.1016/j.rmed.2008.09.005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.rmed.2008.09.005</ArticleId></ArticleIdList></Reference><Reference><Citation>Breitling LP, Saum KU, Schöttker B, Holleczek B, Herth FJ, Brenner H. Pneumonia in the noninstitutionalized older population: A prospective observational study over 11 years. Dtsch Ärztebl Int 2016;113:607. doi: 10.3238/arztebl.2016.0607.</Citation><ArticleIdList><ArticleId IdType="doi">10.3238/arztebl.2016.0607</ArticleId></ArticleIdList></Reference><Reference><Citation>Juthani-Mehta M, De Rekeneire N, Allore H, Chen S, O’Leary JR, Bauer DC, et al. Modifiable risk factors for pneumonia requiring hospitalization of community-dwelling older adults: The Health, Aging, and Body Composition Study. J Am Geriatr Soc 2013;61:1111–1118. doi: 10.1111/jgs.12325.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jgs.12325</ArticleId></ArticleIdList></Reference><Reference><Citation>Ogunmoroti O, Allen NB, Cushman M, Michos ED, Rundek T, Rana JS, et al. Association between life’s simple 7 and noncardiovascular disease: The multi-ethnic study of atherosclerosis. J Am Heart Assoc 2016;5:e003954. doi: 10.1161/JAHA.116.003954.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/JAHA.116.003954</ArticleId></ArticleIdList></Reference><Reference><Citation>Bello S, Menéndez R, Antoni T, Reyes S, Zalacain R, Capelastegui A, et al. Tobacco smoking increases the risk for death from pneumococcal pneumonia. Chest 2014;146:1029–1037. doi: 10.1378/chest.13-2853.</Citation><ArticleIdList><ArticleId IdType="doi">10.1378/chest.13-2853</ArticleId></ArticleIdList></Reference><Reference><Citation>Koivula I, Sten M, Mäkelä PH. Risk factors for pneumonia in the elderly. Am J Med 1994;96:313–320. doi: 10.1016/0002-9343(94)90060-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0002-9343(94)90060-4</ArticleId></ArticleIdList></Reference><Reference><Citation>Hemila H, Virtamo J, Albanes D, Kaprio J. Vitamin E and beta-carotene supplementation and hospital-treated pneumonia incidence in male smokers. Chest 2004;125:557–565. doi: 10.1378/chest.125.2.557.</Citation><ArticleIdList><ArticleId IdType="doi">10.1378/chest.125.2.557</ArticleId></ArticleIdList></Reference><Reference><Citation>Kornum JB, Due KM, Nørgaard M, Tjønneland A, Overvad K, Sørensen HT, et al. Alcohol drinking and risk of subsequent hospitalisation with pneumonia. Eur Respir J 2012;39:149–155. doi: 10.1183/09031936.00000611.</Citation><ArticleIdList><ArticleId IdType="doi">10.1183/09031936.00000611</ArticleId></ArticleIdList></Reference><Reference><Citation>Saitz R, Ghali WA, Moskowitz MA. The impact of alcohol-related diagnoses on pneumonia outcomes. Arch Intern Med 1997;157:1446–1452. doi: 10.1001/archinte.1997.00440340078008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/archinte.1997.00440340078008</ArticleId></ArticleIdList></Reference><Reference><Citation>Gupta NM, Lindenauer PK, Yu PC, Imrey PB, Haessler S, Deshpande A, et al. Association between alcohol use disorders and outcomes of patients hospitalized with community-acquired pneumonia. JAMA Netw Open 2019;2:e195172. doi: 10.1001/jamanetworkopen.2019.5172.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamanetworkopen.2019.5172</ArticleId></ArticleIdList></Reference><Reference><Citation>Merchant AT, Curhan G, Bendich A, Singh VN, Willett WC, Fawzi WW. Vitamin intake is not associated with community-acquired pneumonia in U.S. men. J Nutr 2004;134:439–444. doi: 10.1093/jn/134.2.439.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/jn/134.2.439</ArticleId></ArticleIdList></Reference><Reference><Citation>Merchant AT, Curhan GC, Rimm EB, Willett WC, Fawzi WW. Intake of n-6 and n-3 fatty acids and fish and risk of community-acquired pneumonia in US men. Am J Clin Nutr 2005;82:668–674. doi: 10.1093/ajcn.82.3.668.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ajcn.82.3.668</ArticleId></ArticleIdList></Reference><Reference><Citation>Alperovich M, Neuman MI, Willett WC, Curhan GC. Fatty acid intake and the risk of community-acquired pneumonia in U.S. women. Nutrition 2007;23:196–202. doi: 10.1016/j.nut.2006.11.007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nut.2006.11.007</ArticleId></ArticleIdList></Reference><Reference><Citation>Hemilä H. Vitamin E administration may decrease the incidence of pneumonia in elderly males. Clin Interv Aging 2016;11:1379–1385. doi: 10.2147/CIA.S114515.</Citation><ArticleIdList><ArticleId IdType="doi">10.2147/CIA.S114515</ArticleId></ArticleIdList></Reference><Reference><Citation>Neuman MI, Willett WC, Curhan GC. Vitamin and micronutrient intake and the risk of community-acquired pneumonia in US women. Am J Med 2007;120:330–336. doi: 10.1016/j.amjmed.2006.06.045.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.amjmed.2006.06.045</ArticleId></ArticleIdList></Reference><Reference><Citation>Kunutsor SK, Seidu S, Laukkanen JA. Physical activity reduces the risk of pneumonia: Systematic review and meta-analysis of 10 prospective studies involving 1,044,492 participants. Geroscience 2022;44:519–532. doi: 10.1007/s11357-021-00491-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11357-021-00491-2</ArticleId></ArticleIdList></Reference><Reference><Citation>Hamer M, O’Donovan G, Stamatakis E. Lifestyle risk factors, obesity and infectious disease mortality in the general population: Linkage study of 97,844 adults from England and Scotland. Prev Med 2019;123:65–70. doi: 10.1016/j.ypmed.2019.03.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ypmed.2019.03.002</ArticleId></ArticleIdList></Reference><Reference><Citation>Inoue Y, Koizumi A, Wada Y, Iso H, Watanabe Y, Date C, et al. Risk and protective factors related to mortality from pneumonia among middleaged and elderly community residents: The JACC study. J Epidemiol 2007;17:194–202. doi: 10.2188/jea.17.194.</Citation><ArticleIdList><ArticleId IdType="doi">10.2188/jea.17.194</ArticleId></ArticleIdList></Reference><Reference><Citation>Kornum JB, Nørgaard M, Dethlefsen C, Due KM, Thomsen RW, Tjønneland A, et al. Obesity and risk of subsequent hospitalisation with pneumonia. Eur Respir J 2010;36:1330–1336. doi: 10.1183/09031936.00184209.</Citation><ArticleIdList><ArticleId IdType="doi">10.1183/09031936.00184209</ArticleId></ArticleIdList></Reference><Reference><Citation>Phung DT, Wang Z. Risk of pneumonia in relation to body mass index in Australian Aboriginal people. Epidemiol Infect 2013;141:2497–2502. doi: 10.1017/S0950268813000605.</Citation><ArticleIdList><ArticleId IdType="doi">10.1017/S0950268813000605</ArticleId></ArticleIdList></Reference><Reference><Citation>Kohli S, Sniderman AD, Tchernof A, Lear SA. Ethnic-specific differences in abdominal subcutaneous adipose tissue compartments. Obesity (Silver Spring) 2010;18:2177–2183. doi: 10.1038/oby.2010.94.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/oby.2010.94</ArticleId></ArticleIdList></Reference><Reference><Citation>Kahlon S, Eurich DT, Padwal RS, Malhotra A, Minhas-Sandhu JK, Marrie TJ, et al. Obesity and outcomes in patients hospitalized with pneumonia. Clin Microbiol Infect 2013;19:709–716. doi: 10.1111/j.1469-0691.2012.04003.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1469-0691.2012.04003.x</ArticleId></ArticleIdList></Reference><Reference><Citation>Butler-Laporte G, Harroud A, Forgetta V, Richards JB. Elevated body mass index is associated with an increased risk of infectious disease admissions and mortality: A Mendelian randomization study. Clin Microbiol Infect 2020:S1198–S1743. doi: 10.1016/j.cmi.2020.06.014.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cmi.2020.06.014</ArticleId></ArticleIdList></Reference><Reference><Citation>Torres A, Cilloniz C, Niederman MS, Menéndez R, Chalmers JD, Wunderink RG, et al. Pneumonia. Nat Rev Dis Primers 2021;7:25. doi: 10.1038/s41572-021-00259-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41572-021-00259-0</ArticleId></ArticleIdList></Reference><Reference><Citation>Jain S, Self WH, Wunderink RG, Fakhran S, Balk R, Bramley AM, et al. Community-acquired pneumonia requiring hospitalization among U.S. Adults. N Engl J Med 2015;373:415–427. doi: 10.1056/NEJMoa1500245.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa1500245</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle>